🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose is to demonstrate that vasoreactivity of patients with septic s...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02885168
Treatments Being Tested
Protein S is an anticoagulant protein and a cofactor of protein C. It is re...
Status
Unknown
Location
Laboratoire d'Hématologie - CHU de Strasbourg - France
Start Date
2022-07-01
Trial ID
NCT06182501
The purpose of this study is to evaluate the safety and pharmacokinetic pro...
Status
Completed
Location
Privatklinik Leech
Start Date
2012-08
Trial ID
NCT01660230
Treatments Being Tested
An observational study to determine the effect of APC and Epo in reducing t...
Status
Completed
Location
Lawson Health Research Institute
Start Date
2005-09
Trial ID
NCT00229034
The purpose of this open label, pilot, randomized clinical trial is to eval...
Status
Completed
Location
Washington University Transgender Center
Start Date
2021-08-02
Trial ID
NCT05010707
This is a comparative study performed in 3 groups of patients/subjects: 30 ...
Status
Terminated
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT00361725
The purpose is to determine how Drotrecogin Alfa (activated) will affect pa...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2003-03
Trial ID
NCT00067730
Treatments Being Tested
Recombinant human Activated Protein C (rhAPC) has been shown to reduce the ...
Status
Completed
Location
Academic Medical Center/ University of Amsterdam
Start Date
2008-10
Trial ID
NCT00943267
Treatments Being Tested
The purpose of this study is to test the efficacy of activated Protein C (X...
Status
Terminated
Location
University of California San Francisco at Fresno
Start Date
2005-01
Trial ID
NCT00112164
Treatments Being Tested
The purpose of this study is to evaluate the relative efficacy and safety o...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician
Start Date
2002-12
Trial ID
NCT00049777
Treatments Being Tested